Showing results (1311-1320 of 1,376) with videos related to

Sort By:
Pageof 138
Neurology|August 25, 2017
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findingsAlasdair J Coles, Jeffrey A Cohen, Edward J Fox, et al.
Environmental Research|January 28, 2023
Highly socially vulnerable communities exhibit disproportionately increased viral loads as measured in community wastewaterWilliam M Baldwin, Robert D Dayton, Aaron W Bivins, et al.
The Lancet. Neurology|September 22, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trialsXavier Montalban, Patrick Vermersch, Douglas L Arnold, et al.
Light, Science & Applications|August 20, 2024
Isolated attosecond pulse generation in a semi-infinite gas cell driven by time-gated phase matchingFederico Vismarra, Marina Fernández-Galán, Daniele Mocci, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialAlasdair J Coles, Cary L Twyman, Douglas L Arnold, et al.
Neurology|August 25, 2017
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapyEva Havrdova, Douglas L Arnold, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2022
Magnetization transfer saturation reveals subclinical optic nerve injury in pediatric-onset multiple sclerosisGiulia Longoni, Edgar Martinez Chavez, Kimberly Young, et al.
Archives of Neurology|August 19, 2007
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trialAmit Bar-Or, Timothy Vollmer, Jack Antel, et al.
The New England Journal of Medicine|December 22, 2016
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisStephen L Hauser, Amit Bar-Or, Giancarlo Comi, et al.
Multiple Sclerosis and Related Disorders|March 29, 2022
Progressive retinal changes in pediatric multiple sclerosisGiulia Longoni, Robert A Brown, Ade Oyefiade, et al.
Pageof 138